Inventor · disambiguated record
Christopher Mcguigan
Also filed as: MCGUIGAN CHRISTOPHER
38 granted patents·8 pending applications·1,003 citations·filing 1998–2024
98Inventor score
Top patents by PatentIndex Score
46 records- 0196US11559542B2Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerNuCana plc·Filed 2021·Granted Jan 24, 2023·3 cites·19 claims
- 0296US8933053B2Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerMCGUIGAN CHRISTOPHER·Filed 2012·Granted Jan 13, 2015·37 cites·32 claims
- 0396US7608599B2Antiviral phosphoramidatesROCHE PALO ALTO LLC·Filed 2006·Granted Oct 27, 2009·76 cites·13 claims
- 0496US7018989B2Chemical compoundsUNIV CARDIFF·Filed 2002·Granted Mar 28, 2006·91 cites·8 claims
- 0595US7951787B2Phosphoramidate compounds and methods of useCARDIFF PROTIDES LTD·Filed 2004·Granted May 31, 2011·113 cites·22 claims
- 0694US10022390B2Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerNuCana plc·Filed 2017·Granted Jul 17, 2018·13 cites·20 claims
- 0794US9655915B2Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerNUCANA BIOMED LTD·Filed 2015·Granted May 23, 2017·17 cites·17 claims
- 0894US6455513B1Chemical compoundsUNIV CARDIFF·Filed 1999·Granted Sep 24, 2002·118 cites·33 claims
- 0993US9221866B2Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerNUCANA BIOMED LTD·Filed 2014·Granted Dec 29, 2015·22 cites·69 claims
- 1092US8658616B2Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virusMCGUIGAN CHRISTOPHER·Filed 2007·Granted Feb 25, 2014·55 cites·22 claims
- 1192US7115590B1Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agentsUNIV CARDIFF·Filed 2000·Granted Oct 3, 2006·32 cites·26 claims
- 1290USRE47589EPhosphoramidate compounds and methods of useNuCana plc·Filed 2004·Granted Sep 3, 2019·34 cites·25 claims
- 1390US8759318B2Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infectionsCHAMBERLAIN STANLEY·Filed 2010·Granted Jun 24, 2014·70 cites·78 claims
- 1489US7820631B2Anti-viral pyrimidine nucleoside analoguesREGA FOUNDATION·Filed 2001·Granted Oct 26, 2010·31 cites·17 claims
- 1589US6638919B2Antiviral purine derivativesUNIV CARDIFF·Filed 2001·Granted Oct 28, 2003·35 cites·19 claims
- 1688US11352387B22′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compoundsNuCana plc·Filed 2020·Granted Jun 7, 2022·2 cites·19 claims
- 1788US10993957B2Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancerNuCana plc·Filed 2018·Granted May 4, 2021·4 cites·25 claims
- 1888US10570168B22′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compoundsNuCana plc·Filed 2015·Granted Feb 25, 2020·5 cites·4 claims
- 1987US8263575B2Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancerMCGUIGAN CHRISTOPHER·Filed 2006·Granted Sep 11, 2012·29 cites·24 claims
- 2087US8119779B2Phosphoramidate derivativesMCGUIGAN CHRISTOPHER·Filed 2005·Granted Feb 21, 2012·35 cites·20 claims
- 2187US7414036B2Compounds useful as A3 adenosine receptor agonistsMUSCAGEN LTD·Filed 2004·Granted Aug 19, 2008·89 cites·27 claims
- 2286US7019135B2Anti-viral pyrimidine nucleoside analoguesREGA FOUNDATION·Filed 2001·Granted Mar 28, 2006·32 cites·26 claims
- 2385US11925658B2Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancerNuCana plc·Filed 2023·Granted Mar 12, 2024·0 cites·10 claims
- 2484US8329664B2Anti-viral pyrimidine nucleoside derivativesMCGUIGAN CHRISTOPHER·Filed 2007·Granted Dec 11, 2012·6 cites·20 claims
- 2583US8551965B2Anti-viral pyrimidine nucleoside analoguesMCGUIGAN CHRISTOPHER·Filed 2010·Granted Oct 8, 2013·5 cites·7 claims
- 2682US10906929B2Phosphoramidate nucleoside derivatives as anticancer agentsNuCana plc·Filed 2017·Granted Feb 2, 2021·2 cites·16 claims
- 2780US10662213B2Gemcitabine prodrugsNuCana plc·Filed 2015·Granted May 26, 2020·3 cites·13 claims
- 2879US9321798B2Phosphoramidite derivatives of gemcitabine for use in the treatment of cancerMCGUIGAN CHRISTOPHER·Filed 2011·Granted Apr 26, 2016·4 cites·27 claims
- 2979US8859512B2Anti-viral pyrimidine nucleoside derivativesUNIV CARDIFF·Filed 2012·Granted Oct 14, 2014·3 cites·19 claims
- 3076US2023226092A1Cancer treatments based on gemcitabine prodrugsNuCana plc·Filed 2022·Application pending·0 cites
- 3175US12054510B22′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compoundsNuCana plc·Filed 2022·Granted Aug 6, 2024·0 cites·8 claims
- 3273US6573247B1Anti-viral pyrimidine nucleoside analoguesUNIV CARDIFF·Filed 1998·Granted Jun 3, 2003·36 cites·14 claims
- 3364US11040997B2Process for preparing nucleoside prodrugsNuCana plc·Filed 2018·Granted Jun 22, 2021·0 cites·8 claims
- 3464US2021100825A1Cancer treatments based on gemcitabine prodrugsNuCana plc·Filed 2020·Application pending·0 cites
- 3563US2025163096A12' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compoundsNuCana plc·Filed 2024·Application pending·0 cites
- 3663US2021130387A1Phosphoramidate nucleoside derivatives as anticancer agentsNuCana plc·Filed 2021·Application pending·0 cites
- 3762US11629164B2Gemcitabine prodrugsNuCana plc·Filed 2020·Granted Apr 18, 2023·0 cites·10 claims
- 3862US9427447B2Anti-viral pyrimidine nucleoside derivativesUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2014·Granted Aug 30, 2016·0 cites·11 claims
- 3961US9351970B2Anti-viral pyrimidine nucleoside analoguesREGA FOUNDATION·Filed 2013·Granted May 31, 2016·0 cites·15 claims
- 4055US2018289733A1Cancer treatments based on gemcitabine prodrugsNuCana plc·Filed 2015·Application pending·0 cites
- 4155US2016244476A1Anti-viral pyrimidine nucleoside analoguesREGA FOUND·Filed 2016·Application pending·0 cites
- 4252US8946243B2Compounds and methods for the treatment of viral infectionMARGOLIS LEONID·Filed 2009·Granted Feb 3, 2015·1 cites·12 claims
- 4342US2007191373A1Heterocyclic compounds for use in the treatment of viral infectionsMCGUIGAN CHRISTOPHER·Filed 2004·Application pending·0 cites
- 4440US2019375778A1Adenosine derivatives for use in the treatment of cancerNuCana plc·Filed 2017·Application pending·0 cites
- 4539US11078221B2Phosphorodiamidates and other phosphorus derivatives of fingolimod and related S1P receptor modulatorsUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2018·Granted Aug 3, 2021·0 cites·21 claims
- 4626US8551966B2Chemical compoundsMCGUIGAN CHRISTOPHER·Filed 2011·Granted Oct 8, 2013·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Mcguigan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →